Relugolix Combination Therapy To Improve Quality Of Life In Fibroid Patients Overview This analysis aimed to assess the impact of 52 weeks of treatment with relugolix combination therapy (consisting of relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) on symptoms of uterine fibroids (UF) and quality of life (QoL) in
Tag: fibroids
